Workflow
盈利预期调整
icon
Search documents
Metropolitan Bank Holding Corp. (MCB) Lags Q1 Earnings Estimates
ZACKS· 2025-04-21 22:15
Group 1: Earnings Performance - Metropolitan Bank Holding Corp. reported quarterly earnings of $1.45 per share, missing the Zacks Consensus Estimate of $1.61 per share, and showing a slight decrease from $1.46 per share a year ago, resulting in an earnings surprise of -9.94% [1] - The company posted revenues of $70.59 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 3.50%, compared to year-ago revenues of $66.71 million [2] - Over the last four quarters, the company has surpassed consensus EPS estimates two times and topped consensus revenue estimates three times [2] Group 2: Stock Performance and Outlook - Metropolitan Bank Holding shares have lost about 6.4% since the beginning of the year, while the S&P 500 has declined by 10.2% [3] - The company's earnings outlook is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - The current consensus EPS estimate for the coming quarter is $1.74 on revenues of $71.1 million, and for the current fiscal year, it is $7.31 on revenues of $290.7 million [7] Group 3: Industry Context - The Zacks Industry Rank indicates that the Banks - Northeast industry is currently in the top 23% of over 250 Zacks industries, suggesting a favorable outlook compared to the bottom 50% [8] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5] - The estimate revisions trend for Metropolitan Bank Holding is mixed, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market in the near future [6]
Applied Digital Corporation (APLD) Reports Q3 Loss, Misses Revenue Estimates
ZACKS· 2025-04-14 22:16
Company Performance - Applied Digital Corporation reported a quarterly loss of $0.16 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.11, and an improvement from a loss of $0.52 per share a year ago [1] - The company posted revenues of $52.92 million for the quarter ended February 2025, missing the Zacks Consensus Estimate by 16.75%, but showing an increase from $43.35 million in the same quarter last year [2] - Over the last four quarters, the company has surpassed consensus EPS estimates only once [2] Stock Movement and Outlook - Applied Digital Corporation shares have declined approximately 30.8% since the beginning of the year, compared to a decline of 8.8% for the S&P 500 [3] - The company's earnings outlook is mixed, with current consensus EPS estimates at -$0.11 on revenues of $77.43 million for the upcoming quarter and -$0.96 on revenues of $252.89 million for the current fiscal year [7] Industry Context - The Financial - Miscellaneous Services industry, to which Applied Digital Corporation belongs, is currently ranked in the top 19% of over 250 Zacks industries, indicating a favorable outlook compared to lower-ranked industries [8]
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q4 Loss, Lags Revenue Estimates
ZACKS· 2025-04-01 00:05
Company Performance - Orchestra BioMed Holdings, Inc. reported a quarterly loss of $0.43 per share, which aligns with the Zacks Consensus Estimate, compared to a loss of $0.37 per share a year ago [1] - The company posted revenues of $0.25 million for the quarter ended December 2024, missing the Zacks Consensus Estimate by 67.85%, and down from $0.26 million year-over-year [2] - Over the last four quarters, the company has surpassed consensus EPS estimates two times and topped consensus revenue estimates just once [2][1] Stock Movement and Outlook - Shares of Orchestra BioMed Holdings, Inc. have increased by approximately 10% since the beginning of the year, contrasting with a decline of -5.1% in the S&P 500 [3] - The company's earnings outlook is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - The current consensus EPS estimate for the coming quarter is -$0.46 on revenues of $0.74 million, and for the current fiscal year, it is -$1.95 on revenues of $3.84 million [7] Industry Context - The Medical - Biomedical and Genetics industry, to which Orchestra BioMed belongs, is currently ranked in the top 27% of over 250 Zacks industries, indicating a favorable outlook [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact stock performance [5]